Author

Edith Blackburn

University of KentPrimary ORCID profile (0009-0004-2218-0257 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Edith BlackburniD1 paper · University of Georgia

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Denis T. AkaniD· 1 shared Helen E. GrimsleyiD· 1 shared Jasmine Marie Jakubowski· 1 shared Michelle Dawn GarrettiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Denis T. AkanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Reduced 4E-BP1 activity leads to acquired capivasertib resistance via increased cap-dependent protein synthesis.

Helen E. Grimsley, Jasmine Marie Jakubowski, Denis T. Akan, Edith Blackburn, Michelle Dawn Garrett

This study identifies reduced 4E-BP1 activity and increased cap-dependent protein synthesis as mechanisms of acquired resistance to the AKT inhibitor capivasertib in ovarian cancer.

bioRxiv · Oct 10, 2025 · PreprintCancer Biology